Assessment of Body Image in Patients With Rheumatoid Arthritis

Overview

Investigate body image of patients with rheumatoid arthritis, correlating with self-esteem, function and quality of life.

Full Title of Study: “Body Image in Patients With Rheumatoid Arthritis”

Study Type

  • Study Type: Observational
  • Study Design

Detailed Description

Methods: Forty-three RA patients and thirty-nine control patients between 18 and 70 years were evaluated. The RA group was made up of individuals with a diagnosis of RA and the control group was made up of individuals from the community, paired for gender, age and body mass index. The patients were assessed with regard to body image (Body dysmorphic disorder examination (BDDE)), self-esteem (Rosenberg self-esteem scale), function (Health assessment questionnaire (HAQ)) and quality of life (Short form-36 (SF-36)).

Arms, Groups and Cohorts

  • Rheumatoid Arthritis group1
    • This group had patients with rheumatoid arthritis
  • 2

Clinical Trial Outcome Measures

Primary Measures

  • Body Dysmorphic Disorder Examination
    • Time Frame: baseline

Secondary Measures

  • Short Form – 36
    • Time Frame: baseline
  • Health assessment questionnaire
    • Time Frame: baseline
  • Rosenberg self-esteem scale
    • Time Frame: baseline

Participating in This Clinical Trial

Inclusion Criteria

  • The RA group included patients between 18 and 70 years of age, of either gender, with an established diagnosis of RA based ACR criteria and belonging to functional classes I, II and III. The control group was made up of individuals from the community paired for gender, age and body mass index with RA group. Exclusion Criteria:

  • Individuals with fibromyalgia, neurological disease, psychiatric disorders or other severe co-morbidity were excluded from the study.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 70 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Federal University of São Paulo
  • Provider of Information About this Clinical Study
    • Renata Trajano Borges e Jorge, Federal University of São Paulo
  • Overall Official(s)
    • Jamil Natour, Professor, Study Director, Federal University of Sao Paulo

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.